HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Platelet-activating factor acetylhydrolase is a biomarker of severe anaphylaxis in children.

AbstractBACKGROUND:
There is limited ability to predict the severity of allergic reactions in children. Data derived predominantly from adults have implicated the platelet-activating factor pathway as a potential contributor to severe anaphylaxis. In this study, we sought to prospectively assess involvement of key components of the platelet-activating factor pathway in pediatric patients with anaphylaxis.
METHODS:
Forty-six pediatric patients (<18 years) presenting with acute anaphylaxis were assessed. Anaphylaxis severity was graded and serum anaphylaxis markers were measured acutely and in 36 children who returned for follow-up >4 weeks after their acute presentation. These markers were compared with pediatric laboratory reference sera.
RESULTS:
Severe anaphylaxis was experienced by 12/46 (26%) and mild-moderate anaphylaxis in 34/46 (74%) children. Platelet-activating factor acetylhydrolase (PAF-AH) activity was inversely associated with severe anaphylaxis: 9/12 children with severe anaphylaxis had reduced PAF-AH activity as compared with 14/34 with mild-moderate anaphylaxis (p < .05). Furthermore, 3/3 children who required intensive care had markedly reduced mean PAF-AH (nmol/ml/min) (13.73, 95%CI: 7.42-20.03) versus 20/23 who required ward/emergency department care (17.81, 95%CI: 16.80-18.83; p < .05). In children with anaphylaxis, PAF-AH during acute anaphylaxis was unchanged relative to the child's basal levels (mean, 17.26, 95%CI: 16.10-18.42 vs 17.50, 95%CI: 16.21-18.78, p = .63) and was lower than healthy pediatric controls (mean 19.21; 95%CI:18.21-20.21; p < .05).
CONCLUSION:
Decreased serum PAF-AH activity is a biomarker of severe anaphylaxis. Levels of this enzyme do not change from basal levels during acute anaphylaxis. Our results show that PAF-AH is a biomarker of anaphylaxis severity in children. This key regulatory enzyme may modulate susceptibility to severe anaphylaxis.
AuthorsJulia E M Upton, Jennifer A Hoang, Matilde Leon-Ponte, Yaron Finkelstein, Yue Jennifer Du, Khosrow Adeli, Thomas Eiwegger, Eyal Grunebaum, Peter Vadas
JournalAllergy (Allergy) Vol. 77 Issue 9 Pg. 2665-2676 (09 2022) ISSN: 1398-9995 [Electronic] Denmark
PMID35396721 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2022 EAACI and John Wiley and Sons A/S. Published by John Wiley and Sons Ltd.
Chemical References
  • Biomarkers
  • Platelet Activating Factor
  • 1-Alkyl-2-acetylglycerophosphocholine Esterase
Topics
  • 1-Alkyl-2-acetylglycerophosphocholine Esterase
  • Adult
  • Anaphylaxis (diagnosis, etiology)
  • Biomarkers
  • Child
  • Humans
  • Platelet Activating Factor (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: